MBX compared with CLDX: revenue, margins and what each company keeps, and the suppliers and customers both name

MBXMBX Biosciences, Inc.

Mkt capRevenueRevenue

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

MBXMBX Biosciences, Inc.

CLDXCelldex Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MBX: latest quarter not drawable. CLDX: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MBX 3

—Dr. Richard DiMarchiunlistedsupplier

—Indiana University Research and Technology Corporation ("IURTC")unlistedsupplier

—Trustees of Indiana Universityunlistedsupplier

Shared 0

No shared counterparties.

Only CLDX 1

—Rockefeller Universityunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

MBX, solidCLDX, dashed

MBXMBX Biosciences, Inc.

55.82▲+2.35%· post 55.27

Mkt cap$2.7BRevenue—Revenue—

CLDXCelldex Therapeutics, Inc.

30.10▲+0.70%· post 30.22

ClosedOct 30 '26

Mkt cap$2.4BRevenue$22,000Q2 FY26Revenue$7MFY24

Compare

ClosedOct 30 '26

MBXMBX Biosciences, Inc.

CLDXCelldex Therapeutics, Inc.

55.82▲+2.35%post 55.27

Price

30.10▲+0.70%post 30.22

$2.7B

Mkt cap

$2.4B

—

Revenue

$22,000Q2 FY26

—

Revenue

$7MFY24

MBX55.82▲+2.35%vsCLDX30.10▲+0.70%ClosedOct 30 '26